Cahill, Daniel P.
Harvard University · Massachusetts General Hospital
14 papers on CoChatORCID 0000-0003-2552-6546
Most cited papers
- Verified
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science
Single-cell and spatial transcriptomicsGlioma Diagnosis and Treatment
Cited by 5,063
- Verified
AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
Batchelor, T. T., Sorensen, A. G., di Tomaso, E., Zhang, W.-T., Duda, D. G., Cohen, K. S., Kozak, K. R., Cahill, D. P., Chen, P.-J., Zhu, M., et al. (2007) · Cancer Cell
Angiogenesis and VEGF in CancerGlioma Diagnosis and Treatment
Cited by 1,769
- Verified
Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance
Liau, B. B., Sievers, C., Donohue, L. K., Gillespie, S. M., Flavahan, W. A., Miller, T. E., Venteicher, A. S., Hebert, C. H., Carey, C. D., Rodig, S. J., et al. (2017) · Cell stem cell
Glioma Diagnosis and TreatmentCancer Cells and Metastasis
Cited by 535
- Verified
IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection
Beiko, J., Suki, D., Hess, K. R., Fox, B. D., Cheung, V., Cabral, M., Shonka, N., Gilbert, M. R., Sawaya, R., Prabhu, S. S., et al. (2014) · Neuro-Oncology
Glioma Diagnosis and TreatmentOvarian cancer diagnosis and treatment
Cited by 456
- Verified
Extreme vulnerability of IDH1 mutant cancers to NAD+ depletion
Tateishi, K., Wakimoto, H., Iafrate, A. J., Tanaka, S., Loebel, F., Lelic, N., Wiederschain, D., Bedel, O., Deng, G., Zhang, B., et al. (2015) · Cancer Cell
Cancer, Hypoxia, and MetabolismBiochemical and Molecular Research
Cited by 433
- Verified
Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma
McBrayer, S. K., Mayers, J. R., DiNatale, G. J., Shi, D. D., Khanal, J., Chakraborty, A. A., Sarosiek, K. A., Briggs, K. J., Robbins, A. K., Sewastianik, T., et al. (2018) · Cell
Cancer, Hypoxia, and MetabolismGlioma Diagnosis and Treatment
Cited by 368
- Verified
IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas
Olar, A., Wani, K. M., Alfaro-Munoz, K. D., Heathcock, L. E., van Thuijl, H. F., Gilbert, M. R., Armstrong, T. S., Sulman, E. P., Cahill, D. P., Vera-Bolanos, E., et al. (2015) · Acta Neuropathologica
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 354
- Verified
Characterization of MAD2B and Other Mitotic Spindle Checkpoint Genes
Cahill, D. P., da Costa, L. T., Carson-Walter, E. B., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (1999) · Genomics
Microtubule and mitosis dynamicsCancer-related Molecular Pathways
Cited by 212
- Verified
Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH -Mutant Gliomas
Wakimoto, H., Tanaka, S., Curry, W. T., Loebel, F., Zhao, D., Tateishi, K., Chen, J., Klofas, L. K., Lelic, N., Kim, J. C., et al. (2014) · Clinical Cancer Research
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 190
- Verified
Myc-Driven glycolysis is a therapeutic target in glioblastoma
Tateishi, K., Iafrate, A. J., Ho, Q., Curry, W. T., Batchelor, T. T., Flaherty, K. T., Onozato, M. L., Lelic, N., Sundaram, S., Cahill, D. P., et al. (2016) · Clinical Cancer Research
Cancer, Hypoxia, and MetabolismGlioma Diagnosis and Treatment
Cited by 160
- Verified
BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas
Brastianos, P. K., Twohy, E., Geyer, S., Gerstner, E. R., Kaufmann, T. J., Tabrizi, S., Kabat, B., Thierauf, J., Ruff, M. W., Bota, D. A., et al. (2023) · New England Journal of Medicine
Pituitary Gland Disorders and TreatmentsNeuroendocrine Tumor Research Advances
Cited by 146
- Verified
Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS -Mutant Non–Small Cell Lung Cancer
Nangia, V., Siddiqui, F. M., Caenepeel, S., Timonina, D., Bilton, S. J., Phan, N., Gomez-Caraballo, M., Archibald, H. L., Li, C., Fraser, C., et al. (2018) · Cancer Discovery
Cell death mechanisms and regulationLung Cancer Treatments and Mutations
Cited by 94
- Verified
Glioblastoma-Infiltrating CD8 + T Cells Are Predominantly a Clonally Expanded GZMK + Effector Population
Wang, A. Z., Mashimo, B. L., Schaettler, M. O., Sherpa, N. D., Leavitt, L. A., Livingstone, A. J., Khan, S. M., Li, M., Anzaldua-Campos, M. I., Bradley, J. D., et al. (2024) · Cancer Discovery
Cancer Immunotherapy and BiomarkersGlioma Diagnosis and Treatment
Cited by 73
- Verified
Mutant IDH inhibitors induce lineage differentiation in IDH-mutant oligodendroglioma
Spitzer, A., Gritsch, S., Nomura, M., Jucht, A., Fortin, J., Raviram, R., Weisman, H. R., Gonzalez Castro, L. N., Druck, N., Chanoch-Myers, R., et al. (2024) · Cancer Cell
Glioma Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 69
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free